Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Roche's eye drug beats Lucentis at Phase 2 in wet age-related macular degeneration

pharmafileOctober 31, 2018

Tag: Roche , RG7716 , Genentech's Lucentis

PharmaSources Customer Service